  Numerous prognostic factors are currently assessed histopathologically in
biopsies of canine mast cell tumors to evaluate clinical behavior. In addition,
PCR analysis of the c-Kit exon 11 mutational status is often performed to
evaluate the potential success of a tyrosine kinase inhibitor therapy. This
project aimed at training deep learning models (DLMs) to identify the c-Kit-11
mutational status of MCTs solely based on morphology without additional
molecular analysis. HE slides of 195 mutated and 173 non-mutated tumors were
stained consecutively in two different laboratories and scanned with three
different slide scanners. This resulted in six different datasets
(stain-scanner variations) of whole slide images. DLMs were trained with single
and mixed datasets and their performances was assessed under scanner and
staining domain shifts. The DLMs correctly classified HE slides according to
their c-Kit 11 mutation status in, on average, 87% of cases for the best-suited
stain-scanner variant. A relevant performance drop could be observed when the
stain-scanner combination of the training and test dataset differed.
Multi-variant datasets improved the average accuracy but did not reach the
maximum accuracy of algorithms trained and tested on the same stain-scanner
variant. In summary, DLM-assisted morphological examination of MCTs can predict
c-Kit-exon 11 mutational status of MCTs with high accuracy. However, the
recognition performance is impeded by a change of scanner or staining protocol.
Larger data sets with higher numbers of scans originating from different
laboratories and scanners may lead to more robust DLMs to identify c-Kit
mutations in HE slides.
